YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare

Phase 1

Completed

Conditions: Cutaneous Sarcoidosis
Granuloma Annulare

Interventions: Drug: Tofacitinib 5 mg twice daily

First Posted Date: 2019-04-10

Last Posted Date: 2021-07-14

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT03910543

Locations: 🇺🇸
Yale Center for Clinical Investigation, New Haven, Connecticut, United States

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Phase 3

Recruiting

Conditions: Atrial Fibrillation
Intracerebral Hemorrhage

Interventions: Drug: Apixaban
Drug: Aspirin

First Posted Date: 2019-04-08

Last Posted Date: 2025-01-03

Lead Sponsor: Yale University

Target Recruit Count: 700

Registration Number: NCT03907046

Locations: 🇺🇸
NYC Health + Hospitals/Elmhurst, Elmhurst, New York, United States
🇺🇸
Duke University Hospital, Durham, North Carolina, United States
🇺🇸
Bon Secours St. Mary's Hospital, Richmond, Virginia, United States

and more 164 locations

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

Active, not recruiting

Conditions: Major Depressive Disorder
Healthy
Bipolar Disorder

Interventions: Radiation: [18F]FPEB
Radiation: [11C]APP311

First Posted Date: 2019-04-01

Last Posted Date: 2025-01-03

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT03898297

Locations: 🇺🇸
Yale University PET Center, New Haven, Connecticut, United States

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

Phase 2

Terminated

Conditions: Major Depressive Disorder

Interventions: Drug: Midazolam infusion
Drug: Ketamine infusion

First Posted Date: 2019-03-26

Last Posted Date: 2023-04-24

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT03889756

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

Fatherhood Focused Family Violence Education Program

Not Applicable

Completed

Conditions: Domestic Violence

Interventions: Behavioral: Family Violence Education Program (FVEP)
Behavioral: Fatherhood Focused FVEP (F3)

First Posted Date: 2019-03-21

Last Posted Date: 2021-04-22

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT03883932

Locations: 🇺🇸
Yale University Child Study Center, New Haven, Connecticut, United States

The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders

Phase 1

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Pregnenolone300
Drug: Pregnenolone500
Drug: Placebo

First Posted Date: 2019-03-13

Last Posted Date: 2024-02-05

Lead Sponsor: Yale University

Target Recruit Count: 91

Registration Number: NCT03872128

Locations: 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States
🇺🇸
Yale Stress Center, New Haven, Connecticut, United States

Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients

Completed

Conditions: Breast Cancer
Chemotherapy Induced Peripheral Neuropathy
Paclitaxel Induced Neuropathy

Interventions: Diagnostic Test: Quantitative measures of reduction in Chemotherapy Induced Neuropathy (CIPN) and Cognitive Impairment (CICI) in patients with stage I-III breast cancer

First Posted Date: 2019-03-13

Last Posted Date: 2021-05-03

Lead Sponsor: Yale University

Target Recruit Count: 13

Registration Number: NCT03872141

Locations: 🇺🇸
Smilow Cancer Center, New Haven, Connecticut, United States

Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Behavioral: Electronic Alert

First Posted Date: 2019-02-19

Last Posted Date: 2022-04-22

Lead Sponsor: Yale University

Target Recruit Count: 3124

Registration Number: NCT03845660

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Characterizing Clinical and Pharmacological Neuroimaging Biomarkers

Early Phase 1

Completed

Conditions: Cognitive Impairment

Interventions: Other: MRI
Drug: Ketamine

First Posted Date: 2019-02-15

Last Posted Date: 2020-07-01

Lead Sponsor: Yale University

Target Recruit Count: 143

Registration Number: NCT03842800

Locations: 🇺🇸
Magnetic Resonance Research Center, New Haven, Connecticut, United States

Virtual cOaching in Making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)

Early Phase 1

Completed

Conditions: Elder Abuse

Interventions: Behavioral: Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)

First Posted Date: 2019-02-08

Last Posted Date: 2023-04-20

Lead Sponsor: Yale University

Target Recruit Count: 1012

Registration Number: NCT03834870

Locations: 🇺🇸
St. Raphael Emergency Department, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy